HCP Glaucoma Tools & Resources from LUMIGAN.com



	Efficacy
	Your Patients
	Tools and Resources
	Tutorial Slide library Landmark Trials Calendar Links
	Safety & Pharmacology
	Prescribing Information

Home

References

Newsroom

Home > Tools and Resources

The resources section includes information that may be helpful to you, as well as information to pass on to your patients. The glaucoma animation provides a visual demonstration of disease progression that you can use with your patients to foster communication and prompt questions that they might have. A slide library gives you access to clinical data that can inform your treatment decisions. A summary of landmark trials can be found on the next page. Major conferences and other events can be accessed through our calendar of events . Be sure to browse the Recommended Links section, where you can be connected to over 200 websites. Included in this section: recommended patient links, links to associations and societies, and access to a wealth of major professional journals.

LUMIGAN (bimatoprost ophthalmic solution) 0.03% is for the treatment of high eye pressure, also called intraocular pressure (IOP), in people with open-angle glaucoma or ocular hypertension.

Important Safety Information
LUMIGAN (bimatoprost ophthalmic solution) 0.03% has been reported to cause darkening (pigmentation) of eye color, eyelid skin and eyelashes, as well as increased growth of eyelashes. Pigmentation changes can increase as long as LUMIGAN is used. After stopping LUMIGAN, darkening of eye color is likely to be permanent while darkening of the eyelid skin and eyelash changes may be reversible. The effects of increased darkening beyond 5 years are not known.

The most common side effects are eye redness, growth of eyelashes, and itchy eyes.